rs150811244

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_022489.4(INF2):​c.3612G>A​(p.Ser1204Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,600,200 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., cov: 34)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

INF2
NM_022489.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.66

Publications

0 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 14-104714774-G-A is Benign according to our data. Variant chr14-104714774-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 472858.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.66 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00121 (184/152212) while in subpopulation AFR AF = 0.00426 (177/41558). AF 95% confidence interval is 0.00375. There are 2 homozygotes in GnomAd4. There are 86 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 184 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022489.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
NM_022489.4
MANE Select
c.3612G>Ap.Ser1204Ser
synonymous
Exon 21 of 23NP_071934.3Q27J81-1
INF2
NM_001426862.1
c.3612G>Ap.Ser1204Ser
synonymous
Exon 21 of 23NP_001413791.1
INF2
NM_001426863.1
c.3612G>Ap.Ser1204Ser
synonymous
Exon 21 of 23NP_001413792.1Q27J81-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
ENST00000392634.9
TSL:5 MANE Select
c.3612G>Ap.Ser1204Ser
synonymous
Exon 21 of 23ENSP00000376410.4Q27J81-1
INF2
ENST00000617571.5
TSL:1
n.*461G>A
non_coding_transcript_exon
Exon 20 of 22ENSP00000483829.2A0A087X118
INF2
ENST00000617571.5
TSL:1
n.*461G>A
3_prime_UTR
Exon 20 of 22ENSP00000483829.2A0A087X118

Frequencies

GnomAD3 genomes
AF:
0.00118
AC:
179
AN:
152094
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00413
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000279
AC:
62
AN:
221970
AF XY:
0.000228
show subpopulations
Gnomad AFR exome
AF:
0.00407
Gnomad AMR exome
AF:
0.000159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000305
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000106
AC:
154
AN:
1447988
Hom.:
0
Cov.:
37
AF XY:
0.000100
AC XY:
72
AN XY:
719720
show subpopulations
African (AFR)
AF:
0.00348
AC:
115
AN:
33010
American (AMR)
AF:
0.000213
AC:
9
AN:
42210
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25286
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39462
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
84614
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51440
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5690
European-Non Finnish (NFE)
AF:
0.00000813
AC:
9
AN:
1106546
Other (OTH)
AF:
0.000335
AC:
20
AN:
59730
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00121
AC:
184
AN:
152212
Hom.:
2
Cov.:
34
AF XY:
0.00116
AC XY:
86
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00426
AC:
177
AN:
41558
American (AMR)
AF:
0.000131
AC:
2
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67974
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000527
Hom.:
0
Bravo
AF:
0.00139
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
INF2-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.28
DANN
Benign
0.75
PhyloP100
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150811244; hg19: chr14-105181111; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.